Investment Analysts’ Updated EPS Estimates for October 5th (AGEN, ALK, AMZN, AX, BETA, BMY, BRZE, CPSS, CRVO, CTRE)

Investment Analysts’ updated eps estimates for Monday, October 5th:

Agenus (NASDAQ:AGEN) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $40.00 target price on the stock.

Alaska Air Group (NYSE:ALK) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.

Amazon.com (NASDAQ:AMZN) had its buy rating reissued by analysts at TD Cowen. TD Cowen currently has a $350.00 price target on the stock.

Axos Financial (NYSE:AX) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $128.00 price target on the stock.

BETA Technologies (NYSE:BETA) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $31.00 price target on the stock.

Bristol Myers Squibb (NYSE:BMY) was downgraded by analysts at Leerink Partners from an outperform rating to a market perform rating. They currently have $59.00 target price on the stock, down from their previous target price of $73.00.

Braze (NASDAQ:BRZE) had its market outperform rating reiterated by analysts at Citizens Jmp. Citizens Jmp currently has a $35.00 target price on the stock.

Consumer Portfolio Services (NASDAQ:CPSS) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

CervoMed (NASDAQ:CRVO) had its buy rating reiterated by analysts at HC Wainwright.

CareTrust REIT (NYSE:CTRE) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $43.00 price target on the stock.

Gain Therapeutics (NASDAQ:GANX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $8.00 price target on the stock.

Generate Biomedicines (NASDAQ:GENB) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $30.00 target price on the stock.

Glencore (LON:GLEN) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 630 price target on the stock.

Hermes International (OTCMKTS:HESAY) was downgraded by analysts at UBS Group AG from a neutral rating to a sell rating.

Hammerson (LON:HMSO) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 375 target price on the stock.

Hub Group (NASDAQ:HUBG) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Ibstock (LON:IBST) had its hold rating reissued by analysts at Berenberg Bank. They currently have a GBX 90 price target on the stock.

LB Pharmaceuticals (NASDAQ:LBRX) was downgraded by analysts at Roth Capital from a buy rating to a neutral rating. They currently have $35.00 price target on the stock, down from their previous price target of $37.00.

Lumentum (NASDAQ:LITE) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $1,300.00 target price on the stock.

LPL Financial (NASDAQ:LPLA) had its market outperform rating reissued by analysts at Citizens Jmp. They currently have a $500.00 target price on the stock.

London Stock Exchange Group (LON:LSEG) had its buy rating reissued by analysts at Jefferies Financial Group Inc..

MoonLake Immunotherapeutics (NASDAQ:MLTX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $50.00 target price on the stock.

Millrose Properties (NYSE:MRP) had its market perform rating reissued by analysts at Citizens Jmp.

Oxford Industries (NYSE:OXM) had its neutral rating reiterated by analysts at BTIG Research.

Procore Technologies (NYSE:PCOR) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $65.00 target price on the stock.

PTC (NASDAQ:PTC) had its sector weight rating reissued by analysts at KeyCorp.

PTC (NASDAQ:PTC) was downgraded by analysts at Loop Capital from a buy rating to a hold rating. Loop Capital currently has $205.00 price target on the stock, up from their previous price target of $200.00.

uniQure (NASDAQ:QURE) was downgraded by analysts at Barclays PLC from an overweight rating to an equal weight rating. The firm currently has $28.00 target price on the stock, down from their previous target price of $60.00.

Radware (NASDAQ:RDWR) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Sagimet Biosciences (NASDAQ:SGMT) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $29.00 price target on the stock.

Sphere Entertainment (NYSE:SPHR) was downgraded by analysts at Craig Hallum from a buy rating to a hold rating. Craig Hallum currently has $132.00 price target on the stock.

Sirius Real Estate (LON:SRE) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 134 target price on the stock.

Sirius Real Estate (LON:SRE) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 110 price target on the stock.

Sarepta Therapeutics (NASDAQ:SRPT) had its sell rating reaffirmed by analysts at HC Wainwright. They currently have a $5.00 price target on the stock.

Vanda Pharmaceuticals (NASDAQ:VNDA) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $20.00 price target on the stock.

Verastem (NASDAQ:VSTM) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $18.00 price target on the stock.

Verastem (NASDAQ:VSTM) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $18.00 price target on the stock.

Workday (NASDAQ:WDAY) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $230.00 price target on the stock.

Yesway (NASDAQ:YSWY) had its buy rating reiterated by analysts at Guggenheim. Guggenheim currently has a $32.00 price target on the stock.